Basic Information
ID: ALA4050535
Type: Functional
Description: Antitumor activity against human PC9 cells harboring EGFR exon 19 deletion mutant xenografted in nu/nu mouse assessed as tumor growth inhibition at 50 mg/kg/day administered via oral gavage after 21 days relative to vehicle-control
Organism: Homo sapiens
Cell type: PC-9
Activity Charts
Bioactivity
Activity Types for Assay ALA4050535
TGI
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 489.97 | 4.05 | 4.05 |